17 reports

  • Global Medical Equipment Market, Split By Segments, 2017, $ Billion Segment

Medical equipment devices are designed to aid diagnosis, monitoring or treatment of medical conditions. The medical equipment market in this report is segmented into In-vitro diagnostics, cardiovascular devices, diagnostic equipment, orthopedic devices, hospital supplies, ophthalmic devices, nephrology and urology devices, patient monitoring...

  • In Vitro Diagnostics
  • Medical Supply
  • World
  • Market Size
  • Medtronic, Inc.

Bell Potter Securities Limited acted as placement agent to the company for the offering. ##. ## MEDICAL EQUIPMENT, GLOBAL, NEPHROLOGY AND UROLOGY DEVICES, DEALS, DECEMBER 2017 Table ##: Medical Equipment, Global, Nephrology and Urology Devices, Deals Summary, Number

  • In Vitro Diagnostics
  • World
  • Company
  • Deals & Alliance
  • Stryker Corporation

The company intends to use the funds to accelerate go-to-market activities with a significant expansion in sales hires and marketing efforts. ##. ## MEDICAL EQUIPMENT, GLOBAL, NEPHROLOGY AND UROLOGY DEVICES, DEALS, MARCH 2018 Table ##: Medical Equipment, Global, Nephrology and

  • In Vitro Diagnostics
  • Medical Device
  • World
  • Company
  • Deals & Alliance

The company intends to use the proceeds for sales and regulatory activities in Europe, China and Japan where it is recruiting teams to commercialize its product. ##. ## MEDICAL EQUIPMENT, GLOBAL, NEPHROLOGY AND UROLOGY DEVICES, DEALS, JANUARY 2018 Table ##: Medical Equipment, Global,

  • In Vitro Diagnostics
  • Medical Device
  • World
  • Company
  • Deals & Alliance

The nephrology and Urology devices market recorded six acquisitions worth USD## billion, five equity offerings worth USD##. ##m, three VC deals worth USD##. ##m, one asset transaction worth USD##. ## billion, one debt offering worth USD##m, and one partnership

  • In Vitro Diagnostics
  • Medical Device
  • World
  • Company
  • Deals & Alliance

The nephrology and urology segment recorded five debt offerings worth USD##. ## billion, two VC deal worth USD##. ##m, one acquisition, and one partnership in January 2017.

  • In Vitro Diagnostics
  • Medical Device
  • World
  • Company
  • Deals & Alliance

The transaction is expected to be completed before February ##, 2018, subject to the satisfaction of certain closing conditions including the delivery of certain third-party guarantees and consents. ##. ## MEDICAL EQUIPMENT, GLOBAL, NEPHROLOGY AND UROLOGY DEVICES, DEALS, FEBRUARY ##

  • In Vitro Diagnostics
  • Medical Device
  • World
  • Company
  • Deals & Alliance

FIGURE ## SHOWS THE TOTAL NUMBER OF NEPHROLOGY AND UROLOGY DEVICES DEALS WITH DISCLOSED DEAL VALUES.

  • In Vitro Diagnostics
  • Medical Device
  • World
  • Company
  • Deals & Alliance

The nephrology and urology segment recorded four equity offerings worth USD##. ##m, two debt offerings worth USD##. ##m, two partnerships, one acquisition worth USD## billion, and one VC deal in August 2017.

  • In Vitro Diagnostics
  • Medical Device
  • World
  • Company
  • Deals & Alliance

Deals include financings by, purchases by, partnerships with and acquisitions of nephrology and urology device companies/ assets.

  • In Vitro Diagnostics
  • Medical Device
  • World
  • Company
  • Deals & Alliance

Braun are the major players in the nephrology and urology devices market and accounted for ##% of the market in 2012. ##. ##. ##. ## Nephrology and Urology Devices Overview of the Pharmaceutical and Medical Device Markets Figure ##: Medical Device Market, Israel, Nephrolo

  • In Vitro Diagnostics
  • Israel
  • Middle East
  • Medtronic, Inc.
  • Roche Group

Point-of-care devices used for urinalysis can also use quality controls as reagents.

  • In Vitro Diagnostics
  • North America
  • United States
  • Forecast
  • Sysmex Corporation

The nephrology and urology segment recorded one VC deal worth USD##. ##m, one PE deal worth USD##m, one equity offering worth USD##. ##m, and one acquisition worth USD##. ##m in July 2017.

  • In Vitro Diagnostics
  • Medical Device
  • World
  • Company
  • Deals & Alliance

The nephrology and urology segment recorded two equity offering deals worth USD##. ##m, one venture financing deal worth USD##. ##m and one acquisition deal with undisclosed value in June 2017.

  • In Vitro Diagnostics
  • Medical Device
  • World
  • Company
  • Deals & Alliance
  • ERBA DIAGNOSTICS MANNHEIM GMBH, DEALS BY MARKET, 2011 TO YTD 2017

Summary Erba Diagnostics Mannheim GmbH (Erba Diagnostics) is an in vitro diagnostics company that offers clinical testing products to hospitals, reference labs, and physician clinics. The company develops, manufactures, and commercializes range of automated instruments, test kits, and reagents for clinical chemistry, immunology,...

  • Diagnostics
  • In Vitro Diagnostics
  • Medical Device
  • Germany
  • ERBA DIAGNOSTICS MANNHEIM GMBH

Transasia Bio-Medicals Ltd, Deals By Market, 2011 to YTD 2017 Market In Vitro Diagnostics Nephrology and Urology Devices Other No. of Deals ## ## ## Note: Deals include all announced medical equipment deals from 2011 onwards, deal values included wherever disclosed.

  • In Vitro Diagnostics
  • Medical Device
  • India
  • Deals & Alliance
  • Transasia Bio-Medicals Ltd.

Bard reports its sales in four major product group categories-vascular, urology, oncology and surgical specialty.

  • In Vitro Diagnostics
  • World
  • GE Healthcare Limited
  • Illumina, Inc.
  • QIAGEN N.V.